Vext Engages PartnerCap Securities, LLC

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it has entered into an agreement dated effective as of September 23, 2024 (the "Services Agreement") with PartnerCap Securities, LLC ("PartnerCap"), an affiliate of Partner Capital Group, pursuant to which PartnerCap will provide a number of services which may be considered "Investor Relations Activities" under the policies of the Canadian Securities Exchange, including but not limited to research and publication services. Such services may be delivered in a variety of different mediums through different platforms. The initial term of the Services Agreement will be a period of six months extending from the date of the Services Agreement (the "Initial Term") and the Services Agreement will automatically renew in subsequent three month periods, subject to earlier termination in accordance with its terms.

Pursuant to the Services Agreement, Vext will pay PartnerCap an aggregate cash fee of US$18,000 for the Initial Term and US$9,000 for each subsequent three month renewal term, plus an additional amount to be determined on a case-by-case basis for any services rendered by PartnerCap which are not considered Investor Relations Activities.

PartnerCap is a FINRA registered brokerage firm with an address at 25 Thurmond Way, Bluffton, South Carolina 29910 USA and can be contacted via e-mail at info@partnercap.com or via telephone at 212-737-7347. PartnerCap is arm's length to the Company.

For more details, contact the IR team at investors@vextscience.com.

About Vext Science, Inc.

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.

Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.

For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands

Forward-Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to the Services Agreement, including but not limited to the provision of investor relations activities thereunder and the renewal thereof, and other statements regarding future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.

Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

SOURCE: Vext Science, Inc

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224298